EILEEN BEALE: Open Payments
NPI 1679977276 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 39 payments from 12 companies in 2025. Trend: 2023 $827 · 2024 $1,005 · 2025 $1,443
Food & beverage: $1,443
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $313 |
| Amgen Inc. | 4 | $300 |
| Novo Nordisk Inc | 7 | $231 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $138 |
| PFIZER INC. | 5 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $115 |
| Lilly USA, LLC | 1 | $82 |
| Exact Sciences Corporation | 3 | $52 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Astellas Pharma US Inc | 1 | $26 |
Products named: Otezla, AIRSUPRA, Ozempic, XIFAXAN, Kerendia, BREZTRI, MOUNJARO, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
